The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue

Autor: G. S. Bansal, C Yiangou, Sami Shousha, J. J. Gomm, R. C. Coombes, R. C. Coope, C. L. Johnston, P. J. Browne, N. Groome, J. Walters
Jazyk: angličtina
Rok vydání: 1997
Předmět:
Cancer Research
medicine.medical_specialty
Proteases
medicine.medical_treatment
Immunoblotting
Breast Neoplasms
Biology
HUMAN MAMMARY-GLAND
Fibroblast growth factor
MOUSE
Polymerase Chain Reaction
Paracrine signalling
Mice
breast cancer
Internal medicine
Endopeptidases
medicine
EXTRACELLULAR-MATRIX
Animals
Humans
Receptor
Fibroblast Growth Factor
Type 4

Receptor
Fibroblast Growth Factor
Type 1

Oncology & Carcinogenesis
Autocrine signalling
fibroblast growth factor 1
GENE-EXPRESSION
FACTOR RECEPTOR-1
Science & Technology
CARCINOMA CELLS
Growth factor
SIGNAL TRANSDUCTION
Myoepithelial cell
Receptor Protein-Tyrosine Kinases
protease
LOCALIZATION
Fibroblast growth factor receptor 4
ONCOLOGY
FACTOR MESSENGER-RNA
Molecular biology
Immunohistochemistry
Receptors
Fibroblast Growth Factor

Endocrinology
Female
Life Sciences & Biomedicine
1112 Oncology And Carcinogenesis
Immunostaining
FACTOR FAMILY
Research Article
Zdroj: British Journal of Cancer
Popis: Acidic fibroblast growth factor (FGF1) and two of its receptors, FGFR1 and FGFR4, were localized in cryostat sections of normal, benign and malignant human breast tissue by immunohistochemistry. Without pretreatment, FGF1 staining was mainly seen in normal epithelial cells. However, polymerase chain reaction (PCR) analysis and immunoblotting of isolated normal epithelial and myoepithelial cells showed FGF1 mRNA and protein to be present in both cell types. Following incubation of frozen sections at 37 degrees C in phosphate-buffered saline, FGF1 staining was also revealed in myoepithelial cells and basement membrane adjacent to carcinoma cells. Treatment with protease inhibitors demonstrated that this effect was due to the activity of an endogenous protease. In contrast, FGF1 staining was found to be associated with the stroma adjacent to malignant cells only in the presence of protease inhibitors. FGFR1 and FGFR4 immunostaining was localized to both normal and malignant epithelial cells and to a lesser extent to myoepithelial cells. There was no difference in the staining intensity for the FGF receptors between normal and cancer samples. The change in location of FGF1 between normal and malignant tissues and the sensitivity of stored FGF1 to the action of endogenous proteases raises the possibility of both autocrine and paracrine roles for FGF1 in the normal and malignant human breast. Images Figure 1 Figure 2 Figure 3 Figure 4 Figure 5
Databáze: OpenAIRE